Avirmax Inc

CDMO Services

Our CDMO Services

R&D, Development and Scale-up

Avirmax’s contract manufacturing services are dedicated to innovate and develop novel technologies with its clients to address current challenges in viral vector production based on its state-of-the-art AAV bioprocess technologies in combination with Virovek’s BAC-to-AAV insect system. Our platform, staff and facilities integrate:

  • Scalability & Productivity
  • Speed & Flexibility
  • Safety & Simplicity

The Avirmax team’s extensive experience with this unique vector system and many years in rAAV-based gene therapy process development, regulatory submission and approval at early and late phases will provide our clients with a best-in-class CDMO experience.

Edit
Generation of Viral Banks
0%
US & DS Process Development
0%
Analytical Dev
0%
cGMP Scale-up
0%
Process Qualification & Validation
0%
Stability Studies
0%
Fill & Finish
0%
Virus Validation
0%
Edit
Generation of Viral Banks
0%
US & DS Process Development
0%
Analytical Dev
0%
cGMP Scale-up
0%
Process Qualification & Validation
0%
Stability Studies
0%
Fill & Finish
0%
Virus Validation
0%
Edit
Generation of Viral Banks
0%
US & DS Process Development
0%
Analytical Dev
0%
cGMP Scale-up
0%
Process Qualification & Validation
0%
Stability Studies
0%
Fill & Finish
0%
Virus Validation
0%
Edit
Generation of Viral Banks
0%
US & DS Process Development
0%
Analytical Dev
0%
cGMP Scale-up
0%
Process Qualification & Validation
0%
Stability Studies
0%
Fill & Finish
0%
Virus Validation
0%

Contact Us